Soo K C, Spiro R H, King W, Harvey W, Strong E W
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Am J Surg. 1988 Oct;156(4):281-5. doi: 10.1016/s0002-9610(88)80292-7.
We reviewed a 20-year experience with squamous carcinoma of the gums in 347 patients who received definitive therapy. More than three-quarters of the lesions involved the lower gum and all but 37 patients were previously untreated. The proportion of patients with localized tumors (N0) remained the same (64 percent). Surgery continued to be the treatment of choice in 97 percent of patients, but proportionately more patients had a more conservative procedure which preserved lower jaw continuity. The 5-year determinate survival rate was little changed (54 percent). Advanced clinical stage (stages III and IV), prior dental extraction, bone invasion, and involvement of surgical margins were predictive of a lower survival rate on univariate analysis. Clinical stage was the only significant predictor of survival on multivariate analysis. The impact of adjunctive radiotherapy could not be assessed.
我们回顾了347例接受确定性治疗的牙龈鳞状细胞癌患者的20年治疗经验。超过四分之三的病变累及下牙龈,除37例患者外,其余患者此前均未接受过治疗。局限性肿瘤(N0)患者的比例保持不变(64%)。97%的患者仍选择手术治疗,但采用保留下颌连续性的更保守手术的患者比例相对增加。5年确定生存率变化不大(54%)。单因素分析显示,临床晚期(III期和IV期)、先前拔牙、骨侵犯和手术切缘受累提示生存率较低。多因素分析显示,临床分期是生存的唯一显著预测因素。辅助放疗的影响无法评估。